Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

BACKGROUND. Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation, worsening of pre-existing diabetes, and cardiovascular events. We assessed the benefit of conversion from CNI-based to belatacept-based immunosuppression in diabetic kidney-t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Terrec, Florian, Jouve, Thomas, Naciri-Bennani, Hamza, Benhamou, Pierre-Yves, Malvezzi, Paolo, Janbon, Benedicte, Giovannini, Diane, Rostaing, Lionel, Noble, Johan
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
Kidney Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964931/
https://ncbi.nlm.nih.gov/pubmed/32047845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000964
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados